Murine vaginal candidiasis model

BZ Beini Zeng
JL Jiachen Li
YW Yajie Wang
PC Pengxiang Chen
XW Xiaohong Wang
JC Jianfeng Cui
LL Lidong Liu
XH Xiaoyan Hu
QC Qian Cao
YX Ying Xiao
JD Junlu Dong
YS Yundong Sun
YZ Yabin Zhou
request Request a Protocol
ask Ask a question
Favorite

The murine vaginal candidiasis model was established with Kunming mice following a previously described method with minor modifications [2022]. Fifty-three female Kunming mice (28–32 g body weight) were used at 7 to 8 weeks of age. The mice were randomly assigned to 2 groups with five mice each: either vehicle or suloctidil and were maintained under a pseudoestrus condition by subcutaneous injection of 0.2 mg of estradiol benzoate (every other day, CEN’S, Hangzhou, China) 7 days prior to infection and until the completion of the study. A C. albicans suspension (1×107 cells/mL) in 20 μL of PBS was administered to the vaginas of the mice. The filaments in the mouse vaginas were observed after 7 days of infection. Intravaginal treatment with 50 μL of 256 μg/mL suloctidil was administered into the vaginas of mice every day until day +21. PBS was used as a control. After various treatment times, the mice were sacrificed and the vaginal lumen was thoroughly washed and scraped with 1 mL of PBS. To determine the fungal load in the vagina, 100 μL of lavage fluid from each mouse was plated on YPD agar plus ceftriaxone (50 μg/mL, Roche, Basel, Switzerland). CFUs were then evaluated.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A